Endoxifen in Adults With Hormone Receptor Positive Solid Tumors
Phase I Trial of Z-Endoxifen in Adults With Refractory Hormone Receptor-Positive Breast Cancer, Desmoid Tumors, Gynecologic Tumors, or Other Hormone Receptor-Positive Solid Tumors
Sponsor: National Cancer Institute (NCI)
A PHASE1 clinical study on Desmoid and Gynecologic, this trial is completed. The trial is conducted by National Cancer Institute (NCI) and has accumulated 73 data snapshots since 2011. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
73 versions recorded-
Jan 2026 — Present [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
-
Dec 2025 — Jan 2026 [monthly]
Active Not Recruiting PHASE1
-
Oct 2025 — Dec 2025 [monthly]
Active Not Recruiting PHASE1
-
Sep 2025 — Oct 2025 [monthly]
Active Not Recruiting PHASE1
-
Aug 2025 — Sep 2025 [monthly]
Active Not Recruiting PHASE1
▶ Show 68 earlier versions
-
Jul 2025 — Aug 2025 [monthly]
Active Not Recruiting PHASE1
-
Jun 2025 — Jul 2025 [monthly]
Active Not Recruiting PHASE1
-
May 2025 — Jun 2025 [monthly]
Active Not Recruiting PHASE1
-
Apr 2025 — May 2025 [monthly]
Active Not Recruiting PHASE1
-
Mar 2025 — Apr 2025 [monthly]
Active Not Recruiting PHASE1
-
Feb 2025 — Mar 2025 [monthly]
Active Not Recruiting PHASE1
-
Jan 2025 — Feb 2025 [monthly]
Active Not Recruiting PHASE1
-
Dec 2024 — Jan 2025 [monthly]
Active Not Recruiting PHASE1
-
Nov 2024 — Dec 2024 [monthly]
Active Not Recruiting PHASE1
-
Oct 2024 — Nov 2024 [monthly]
Active Not Recruiting PHASE1
-
Sep 2024 — Oct 2024 [monthly]
Active Not Recruiting PHASE1
-
Aug 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE1
-
Jul 2024 — Aug 2024 [monthly]
Active Not Recruiting PHASE1
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE1
-
May 2024 — Jun 2024 [monthly]
Active Not Recruiting PHASE1
-
Apr 2024 — May 2024 [monthly]
Active Not Recruiting PHASE1
-
Mar 2024 — Apr 2024 [monthly]
Active Not Recruiting PHASE1
-
Feb 2024 — Mar 2024 [monthly]
Active Not Recruiting PHASE1
-
Jan 2024 — Feb 2024 [monthly]
Active Not Recruiting PHASE1
-
Dec 2023 — Jan 2024 [monthly]
Active Not Recruiting PHASE1
-
Sep 2023 — Dec 2023 [monthly]
Active Not Recruiting PHASE1
-
Aug 2023 — Sep 2023 [monthly]
Active Not Recruiting PHASE1
-
Jul 2023 — Aug 2023 [monthly]
Active Not Recruiting PHASE1
-
Jun 2023 — Jul 2023 [monthly]
Active Not Recruiting PHASE1
-
May 2023 — Jun 2023 [monthly]
Active Not Recruiting PHASE1
-
Apr 2023 — May 2023 [monthly]
Active Not Recruiting PHASE1
-
Feb 2023 — Apr 2023 [monthly]
Active Not Recruiting PHASE1
-
Jan 2023 — Feb 2023 [monthly]
Active Not Recruiting PHASE1
-
Dec 2022 — Jan 2023 [monthly]
Active Not Recruiting PHASE1
-
Nov 2022 — Dec 2022 [monthly]
Active Not Recruiting PHASE1
-
Sep 2022 — Nov 2022 [monthly]
Active Not Recruiting PHASE1
-
Jul 2022 — Sep 2022 [monthly]
Active Not Recruiting PHASE1
-
Jun 2022 — Jul 2022 [monthly]
Active Not Recruiting PHASE1
-
May 2022 — Jun 2022 [monthly]
Active Not Recruiting PHASE1
-
Apr 2022 — May 2022 [monthly]
Active Not Recruiting PHASE1
-
Mar 2022 — Apr 2022 [monthly]
Active Not Recruiting PHASE1
-
Feb 2022 — Mar 2022 [monthly]
Active Not Recruiting PHASE1
-
Jan 2022 — Feb 2022 [monthly]
Active Not Recruiting PHASE1
-
Nov 2021 — Jan 2022 [monthly]
Active Not Recruiting PHASE1
-
Oct 2021 — Nov 2021 [monthly]
Active Not Recruiting PHASE1
-
Sep 2021 — Oct 2021 [monthly]
Active Not Recruiting PHASE1
-
Jun 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE1
-
May 2021 — Jun 2021 [monthly]
Active Not Recruiting PHASE1
-
Apr 2021 — May 2021 [monthly]
Active Not Recruiting PHASE1
-
Mar 2021 — Apr 2021 [monthly]
Active Not Recruiting PHASE1
-
Feb 2021 — Mar 2021 [monthly]
Active Not Recruiting PHASE1
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting PHASE1
-
Dec 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE1
-
Oct 2020 — Dec 2020 [monthly]
Active Not Recruiting PHASE1
-
Sep 2020 — Oct 2020 [monthly]
Active Not Recruiting PHASE1
-
Jul 2020 — Sep 2020 [monthly]
Active Not Recruiting PHASE1
-
Jun 2020 — Jul 2020 [monthly]
Active Not Recruiting PHASE1
-
May 2020 — Jun 2020 [monthly]
Active Not Recruiting PHASE1
-
Mar 2020 — May 2020 [monthly]
Active Not Recruiting PHASE1
-
Jan 2020 — Mar 2020 [monthly]
Active Not Recruiting PHASE1
-
Dec 2019 — Jan 2020 [monthly]
Active Not Recruiting PHASE1
-
Oct 2019 — Dec 2019 [monthly]
Active Not Recruiting PHASE1
-
Jun 2019 — Oct 2019 [monthly]
Active Not Recruiting PHASE1
-
May 2019 — Jun 2019 [monthly]
Active Not Recruiting PHASE1
-
Mar 2019 — May 2019 [monthly]
Active Not Recruiting PHASE1
-
Jan 2019 — Mar 2019 [monthly]
Active Not Recruiting PHASE1
-
Dec 2018 — Jan 2019 [monthly]
Active Not Recruiting PHASE1
-
Aug 2018 — Dec 2018 [monthly]
Active Not Recruiting PHASE1
-
Jul 2018 — Aug 2018 [monthly]
Active Not Recruiting PHASE1
-
Jun 2018 — Jul 2018 [monthly]
Active Not Recruiting PHASE1
-
Feb 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Feb 2017 — Feb 2018 [monthly]
Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1
First recorded
Mar 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .